Inwald, E. C., Ortmann, O., Zeman, F., Koller, M., Hofstädter, F., Gerstenhauer, M., & Klinkhammer-Schalke, M. (2014). Guideline Concordant Therapy Prolongs Survival in HER2-Positive Breast Cancer Patients: Results from a Large Population-Based Cohort of a Cancer Registry. Hindawi Publishing Corporation.
Citação norma ChicagoInwald, E. C., O. Ortmann, F. Zeman, M. Koller, F. Hofstädter, M. Gerstenhauer, and M. Klinkhammer-Schalke. Guideline Concordant Therapy Prolongs Survival in HER2-Positive Breast Cancer Patients: Results From a Large Population-Based Cohort of a Cancer Registry. Hindawi Publishing Corporation, 2014.
Citação norma MLAInwald, E. C., et al. Guideline Concordant Therapy Prolongs Survival in HER2-Positive Breast Cancer Patients: Results From a Large Population-Based Cohort of a Cancer Registry. Hindawi Publishing Corporation, 2014.